Clinical Trial Update: Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updating safety and immune response to an HIV-1 DNA vaccine and a booster in HIV-uninfected adults in East Africa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VRC-HIVADV014-00-VP
• VRC-HIVDNA016-00-VP

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED